Prevail Study

Mount Sinai Hospital in Toronto is conducting the PREVAIL Study, a government-funded clinical trial aimed at researching methods to protect insulin-producing cells in individuals with early Type 2 Diabetes Mellitus (T2DM). The study seeks participants who have had diabetes for 0-7 years, are on two oral medications, and are between the ages of 30 and 80.

Participants will be required to attend four study visits over a span of 20 weeks. The PREVAIL Study is focused on slowing the progression of diabetes and is led by a team of dedicated investigators and researchers.

Generated from the website